Evidence map›Paper›PMID 40328797›Full record

ArticleNature communications2025

Large-scale transcriptome mining enables macrocyclic diversification and improved bioactivity of the stephanotic acid scaffold.

Xiaofeng Wang, Khadija Shafiq, Derrick A Ousley, Desnor N Chigumba, Dulciana Davis, Kali M McDonough, Lisa S Mydy, Jonathan Z Sexton, Roland D Kersten

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaofeng Wang *Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Khadija Shafiq *Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Derrick A Ousley *Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Desnor N ChigumbaDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Dulciana DavisDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Kali M McDonoughDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Lisa S MydyDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.
Jonathan Z SextonDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-9244-5888
Roland D KerstenDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, USA. rkersten@umich.edu.ORCID http://orcid.org/0000-0001-5811-7330

Funding

Interdepartmental Training in Pharmacological SciencesT32GM140223 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Lori L. Isom · 2021 to 2026
$3.8M
Discovery, Biosynthesis and Engineering of Side-Chain-Macrocyclic Plant PeptidesR35GM146934 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Roland David Kersten · 2022 to 2026
$1.8M
Modeling Drug Induced Liver Injury with Patient-Derived Liver Organoids and Microfluidic ChipsR01GM152417 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROBERT J FONTANA, Jonathan Zachary Sexton · 2024 to 2026
$1.7M
Laser-based high content imaging microscopeS10OD034245 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SEXTON, JONATHAN ZACHARY · 2024 to 2024
$1.4M
Mechanistic Investigation of Copper-Dependent Peptide Cyclases for Macrocycle EngineeringF32GM146395 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYDY, LISA SUSANNAH · 2022 to 2023
$152k
Biosynthetic Development and Diversification of Moroidin Peptides for Cancer ApplicationsF31GM155959 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAFIQ, KHADIJA · 2024 to 2025
$49k
NIGMS NIH HHS F31 GM155959NIGMS NIH HHS F32 GM146395NIGMS NIH HHS R01 GM152417NIGMS NIH HHS R35 GM146934NIH HHS S10 OD034245Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation) Predoctoral FellowshipU.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) F31GM155959U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) F32GM146395U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM152417U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM146934U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM140223U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) S10OD034245
6 · The paper itself

Abstract

Nearly 10,000 plant species are represented by RNA-seq datasets in the NCBI sequence read archive, which are difficult to search in unassembled format due to database size. Here, we optimize RNA-seq assembly to transform most of this public RNA-seq data to a searchable database for biosynthetic gene discovery. We test our transcriptome mining pipeline towards the diversification of moroidins, which are plant ribosomally-synthesized and posttranslationally-modified peptides (RiPPs) biosynthesized from copper-dependent peptide cyclases. Moroidins are bicyclic compounds with a conserved stephanotic acid scaffold, which becomes cytotoxic to non-small cell lung adenocarcinoma cells with an additional C-terminal macrocycle. We discover moroidin analogs with second ring structures diversified at the crosslink and the non-crosslinked residues including a moroidin analog from water chickweed, which exhibits higher cytotoxicity against lung adenocarcinoma cells than moroidin. Our study expands stephanotic acid-type peptides to grasses, Lowiaceae, mints, pinks, and spurges while demonstrating that large-scale transcriptome mining can broaden the medicinal chemistry toolbox for chemical and biological exploration of eukaryotic RiPP lead structures.

Indexed as

Macrocyclic CompoundsTranscriptomeCell Line, TumorData MiningGene Expression ProfilingHumansLung NeoplasmsMacrocyclic Compounds

Identifiers

PMID40328797
PMCPMC12056006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.